What Kevin Ryan has said about Transcend Therapeutics

1 quote · 1 episode · Sep 24, 2026

Kevin Ryan, American entrepreneur and investor, founder and CEO of AlleyCorp and former CEO of DoubleClick, has been quoted on Transcend Therapeutics once in 1 episode of The Tim Ferriss Show, most recently on September 24, 2026. Each quote below is verbatim and links to the moment it was said.

In their words

Ryan says the high cost of FDA approval is why psychedelic development needed a for-profit company rather than philanthropy alone.
“it takes roughly $200 to $250 million to get one compound through the FDA process”
The Tim Ferriss Show: #884: How to Spot 10-Year Trends and Build Billion-Dollar Companies — Kevin Ryan of DoubleClick, MongoDB, Business Insider, and Many More (Sep 24, 2026) · Listen from 53:37

Episodes

#884: How to Spot 10-Year Trends and Build Billion-Dollar Companies — Kevin Ryan of DoubleClick, MongoDB, Business Insider, and Many More
The Tim Ferriss Show · Sep 24, 2026 · 1 h 26 min
Tim Ferriss talks with investor Kevin Ryan about spotting 10-year trends, building DoubleClick, Gilt, Business Insider and MongoDB, psychedelic drug development, deep tech, and immigration.

Kevin Ryan on other topics

Entrepreneurship · 3 quotes
Income inequality in the United States · 2 quotes
Robotics · 2 quotes
Methylone · 2 quotes
AlleyCorp · 2 quotes
Trend forecasting · 2 quotes
Illegal immigration to the United States · 1 quote
MongoDB · 1 quote